The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association
Open accessAbstract
Background: In 2007, the American Heart Association published updated evidence-based guidelines on the recommended use of antibiotic prophylaxis to prevent viridans group streptococcal (VGS) infective endocarditis (IE) in cardiac patients undergoing invasive procedures. The 2007 guidelines significantly scaled back the underlying conditions for which antibiotic prophylaxis was recommended, leaving only 4 categories thought to confer the highest risk of adverse outcome. The purpose of this update is to examine interval evidence of the acceptance and impact of the 2007 recommendations on VGS IE and, if needed, to make revisions based on this evidence. Methods and Results: A writing group was formed consisting of experts in prevention and treatment of infective endocarditis including members of the American Dental Association, the Infectious Diseases Society of America, and the American Academy of Pediatrics, in addition to the American Heart Association. MEDLINE database searches were done for English language articles on compliance with the recommendations in the 2007 guidelines and the frequency of and morbidity or mortality from VGS IE after publication of the 2007 guidelines. Overall, there was good general awareness of the 2007 guidelines but variable compliance with recommendations. There was no convincing evidence that VGS IE frequency, morbidity, or mortality has increased since 2007. Conclusions: On the basis of a review of the available evidence, there are no recommended changes to the 2007 VGS IE prevention guidelines. We continue to recommend VGS IE prophylaxis only for categories of patients at highest risk for adverse outcome while emphasizing the critical role of good oral health and regular access to dental care for all. Randomized controlled studies to determine whether antibiotic prophylaxis is effective against VGS IE are needed to further refine recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shared decision making: A model for clinical practice
Elwyn, G., Frosch, D., Thomson, R., Joseph-Williams, N., Lloyd, A., Kinnersley, P., Cording, E., Tomson, D., Dodd, C., Rollnick, S., et al. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2077-6 · Cited by 4,405
Wilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,814
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationMandell, Douglas, and Bennett's principles and practice of infectious diseases
Gillespie, S. H. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70159-6 · Cited by 705
Pant, S., Patel, N. J., Deshmukh, A., Golwala, H., Patel, N., Badheka, A., Hirsch, G. A., & Mehta, J. L. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.518 · Cited by 604
Dayer, M. J., Jones, S., Prendergast, B., Baddour, L. M., Lockhart, P. B., & Thornhill, M. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62007-9 · Cited by 538
Self-citationPrevention of Infective Endocarditis
Durack, D. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320107 · Cited by 411
Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications
Duval, X., Delahaye, F., Alla, F., Tattevin, P., Obadia, J.-F., Le Moing, V., Doco-Lecompte, T., Celard, M., Poyart, C., Strady, C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.029 · Cited by 383
Trends in Infective Endocarditis in California and New York State, 1998-2013
Toyoda, N., Chikwe, J., Itagaki, S., Gelijns, A. C., Adams, D. H., & Egorova, N. N. (2017) · JAMA · doi:10.1001/jama.2017.4287 · Cited by 340
Thornhill, M. H., Dayer, M. J., Forde, J. M., Corey, G. R., Chu, V. H., Couper, D. J., & Lockhart, P. B. (2011) · BMJ · doi:10.1136/bmj.d2392 · Cited by 254
Self-citation
Cited by
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Self-citationCalcific Aortic Stenosis: A Review
Otto, C. M., Newby, D. E., & Hillis, G. S. (2024) · JAMA · doi:10.1001/jama.2024.16477 · Cited by 97
Metadata
- Authors
- Wilson, W. R., Gewitz, M., Lockhart, P. B., Bolger, A. F., DeSimone, D. C., Kazi, D. S., Couper, D. J., Beaton, A., Kilmartin, C., Miro, J. M., Sable, C., Jackson, M. A., Baddour, L. M., & On behalf of the American Heart Association Young Hearts Rheumatic Fever, E. A. K. D. C. O. T. C. O. L. C. H. D. A. H. H. I. T. Y. C. O. C. A. S. N. A. T. C. O. Q. O. C. A. O. R.
- Venue
- Circulation
- Published
- 2021-05-18
- Volume
- 143
- Issue
- 20
- Pages
- e963-e978
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3153822106
- Cited by
- 338
- References
- 62
- FWCI
- 32.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/cir.0000000000000969
- The paper
- Wilson, W. R., Gewitz, M., Lockhart, P. B., Bolger, A. F., DeSimone, D. C., Kazi, D. S., Couper, D. J., Beaton, A., Kilmartin, C., Miro, J. M., Sable, C., Jackson, M. A., Baddour, L. M., & On behalf of the American Heart Association Young Hearts Rheumatic Fever, E. A. K. D. C. O. T. C. O. L. C. H. D. A. H. H. I. T. Y. C. O. C. A. S. N. A. T. C. O. Q. O. C. A. O. R. (2021). Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. https://doi.org/10.1161/cir.0000000000000969
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.